Literature DB >> 7559541

Resolution of the facilitated transport of dehydroascorbic acid from its intracellular accumulation as ascorbic acid.

J C Vera1, C I Rivas, F V Velásquez, R H Zhang, I I Concha, D W Golde.   

Abstract

We performed a detailed kinetic analysis of the uptake of dehydroascorbic acid by HL-60 cells under experimental conditions that enabled the differentiation of dehydroascorbic acid transport from the intracellular reduction/accumulation of ascorbic acid. Immunoblotting and immunolocalization experiments identified GLUT1 as the main glucose transporter expressed in the HL-60 cells. Kinetic analysis allowed the identification of a single functional activity involved in the transport of dehydroascorbic acid in the HL-60 cells. Transport was inhibited in a competitive manner by both 3-O-methyl-D-glucose and 2-deoxy-D-glucose. In turn, dehydroascorbic acid competitively inhibited the transport of both sugars. A second functional component identified in experiments measuring the accumulation of ascorbic acid appears to be associated with the intracellular reduction of dehydroascorbic acid to ascorbic acid and is not directly involved in the transport of dehydroascorbic acid via GLUT1. Transport of dehydroascorbic acid by HL-60 cells was independent of the presence of external Na+, whereas the intracellular accumulation of ascorbic acid was found to be a Na(+)-sensitive process. Thus, the transport of dehydroascorbic acid via glucose transporters is a Na(+)-independent process which is kinetically and biologically separable from the reduction of dehydroascorbic acid to ascorbic acid and its subsequent intracellular accumulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7559541     DOI: 10.1074/jbc.270.40.23706

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Defective glucose transport across brain tissue barriers: a newly recognized neurological syndrome.

Authors:  J Klepper; D Wang; J Fischbarg; J C Vera; I T Jarjour; K R O'Driscoll; D C De Vivo
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

Review 2.  Ascorbic acid: chemistry, biology and the treatment of cancer.

Authors:  Juan Du; Joseph J Cullen; Garry R Buettner
Journal:  Biochim Biophys Acta       Date:  2012-06-20

Review 3.  Targeting cancer vulnerabilities with high-dose vitamin C.

Authors:  Bryan Ngo; Justin M Van Riper; Lewis C Cantley; Jihye Yun
Journal:  Nat Rev Cancer       Date:  2019-05       Impact factor: 60.716

4.  Alzheimer's disease and the Blood-Brain Barrier: Past, Present and Future.

Authors:  Gene L Bowman; Joseph F Quinn
Journal:  Aging health       Date:  2008-02-01

5.  Dehydroascorbic acid uptake in a human keratinocyte cell line (HaCaT) is glutathione-independent.

Authors:  I Savini; S Duflot; L Avigliano
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

6.  Interaction of respiratory burst and uptake of dehydroascorbic acid in differentiated HL-60 cells.

Authors:  H Laggner; H Goldenberg
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

7.  Potentiation of an antimalarial oxidant drug.

Authors:  R W Winter; M Ignatushchenko; O A Ogundahunsi; K A Cornell; A M Oduola; D J Hinrichs; M K Riscoe
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

8.  Vitamin C is a kinase inhibitor: dehydroascorbic acid inhibits IkappaBalpha kinase beta.

Authors:  Juan M Cárcamo; Alicia Pedraza; Oriana Bórquez-Ojeda; Bing Zhang; Roberto Sanchez; David W Golde
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

9.  Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs.

Authors:  Mark L Heaney; Jeffrey R Gardner; Nicos Karasavvas; David W Golde; David A Scheinberg; Emily A Smith; Owen A O'Connor
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

Review 10.  Vitamin C transporters.

Authors:  C I Rivas; F A Zúñiga; A Salas-Burgos; L Mardones; V Ormazabal; J C Vera
Journal:  J Physiol Biochem       Date:  2008-12       Impact factor: 4.158

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.